نتائج البحث - Angela Genge

تنقيح النتائج
  1. 1
    Diagnostic delay in amyotrophic lateral sclerosis

    Diagnostic delay in amyotrophic lateral sclerosis حسب Kelly Gwathmey, Philippe Corcia, Christopher McDermott, Angela Genge, Stefan Sennfält, Mamede de Carvalho, Caroline Ingre

    منشور في 2023
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Cerebral atrophy in amyotrophic lateral sclerosis parallels the pathological distribution of TDP43

    Cerebral atrophy in amyotrophic lateral sclerosis parallels the pathological distribution of TDP43 حسب Mahsa Dadar, Ana L. Manera, Lorne Zinman, Lawrence Korngut, Angela Genge, Simon J. Graham, Richard Frayne, D. Louis Collins, Sanjay Kalra

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS

    A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS حسب Sanjay Kalra, Hans‐Peter Müller, Abdullah Ishaque, Lorne Zinman, Lawrence Korngut, Angela Genge, Christian Beaulieu, Richard Frayne, Simon J. Graham, Jan Kassubek

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis

    Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis حسب Angela Genge, Leonard H. van den Berg, Glen Frick, Steve Han, Cori Abikoff, Adam Simmons, Qun Lin, Kaushik Patra, Erik Kupperman, James Berry

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis

    Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis حسب Gary L. Pattee, Angela Genge, Philippe Couratier, Christian Lunetta, Gen Sobue, Masashi Aoki, Hiide Yoshino, Carlayne E. Jackson, James Wymer, Alejandro Salah, Sally Nelson

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Respiratory measures in amyotrophic lateral sclerosis

    Respiratory measures in amyotrophic lateral sclerosis حسب Noah Lechtzin, Merit Cudkowicz, Mamede de Carvalho, Angela Genge, Orla Hardiman, Hiroshi Mitsumoto, Jesús S. Mora, Jeremy M. Shefner, Leonard H. van den Berg, Jinsy Andrews

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Reliability and validity of speech & pause measures during passage reading in ALS

    Reliability and validity of speech & pause measures during passage reading in ALS حسب Carolina Barnett, Jordan R. Green, Reeman Marzouqah, Kaila L. Stipancic, James Berry, Lawrence Korngut, Angela Genge, Christen Shoesmith, Hannah Briemberg, Agessandro Abrahão, Sanjay Kalra, Lorne Zinman, Yana Yunusova

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Rate of speech decline in individuals with amyotrophic lateral sclerosis

    Rate of speech decline in individuals with amyotrophic lateral sclerosis حسب Marziye Eshghi, Yana Yunusova, Kathryn P. Connaghan, Bridget J. Perry, Marc F. Maffei, James Berry, Lorne Zinman, Sanjay Kalra, Lawrence Korngut, Angela Genge, Annie Dionne, Jordan R. Green

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel

    Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel حسب Mark A. Tarnopolsky, Hans Katzberg, Basil J. Petrof, Sandra Sirrs, Harvey B. Sarnat, Kimberley Myers, Nicolas Dupré, Dubravka Dodig, Angela Genge, Shannon L. Venance, Lawrence Korngut, Julian Raiman, Anzalee Khan

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS

    Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS حسب Namita Goyal, James Berry, Anthony J. Windebank, Nathan P. Staff, Nicholas J. Maragakis, Leonard H. van den Berg, Angela Genge, Robert G. Miller, Robert H. Baloh, R. Kern, Yaël Gothelf, Chaim Lebovits, Merit Cudkowicz

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Understanding the use of NIV in ALS: results of an international ALS specialist survey

    Understanding the use of NIV in ALS: results of an international ALS specialist survey حسب Terry Heiman‐Patterson, Merit Cudkowicz, Mamede de Carvalho, Angela Genge, Orla Hardiman, Carlayne E. Jackson, Noah Lechtzin, Hiroshi Mitsumoto, Vincenzo Silani, Jinsy Andrews, Dafeng Chen, Sarah Kulke, Stacy A. Rudnicki, Leonard H. van den Berg

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study <scp>MT</scp>‐1186‐<scp>A02</scp>)

    Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study <scp>MT</scp>‐... حسب Jeffrey D. Rothstein, Angela Genge, Amélia M. Silva, Lorne Zinman, Marvin Chum, Adriano Chiò, Gen Sobue, Masashi Aoki, Hiide Yoshino, Manabu Doyu, Daniel Selness, Vesna Todorović, Noah J. Sasson, Manabu Hirai, Fumihiro Takahashi, Alejandro Salah, Art Wamil, Stephen Apple

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Safety Extension Study of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis for up to an Additional 96 Weeks of Treatment

    Safety Extension Study of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis for up to an Additional 96 Weeks of Treatment حسب Angela Genge, Gary L. Pattee, Gen Sobue, Masashi Aoki, Hiide Yoshino, Philippe Couratier, Christian Lunetta, Susanne Petri, Daniel Selness, Vesna Todorović, Noah J. Sasson, Manabu Hirai, Fumihiro Takahashi, Alejandro Salah, Stephen Apple, Art Wamil, Alexander Kalin, Carlayne E. Jackson

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches

    Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches حسب Corey T. McMillan, Joanne Wuu, Katya Rascovsky, Stephanie Cosentino, Murray Grossman, Lauren Elman, Colin Quinn, Luis Rosario, Jessica Stark, Volkan Granit, Hannah Briemberg, Sneha Chenji, Annie Dionne, Angela Genge, Wendy Johnston, Lawrence Korngut, Christen Shoesmith, Lorne Zinman, Sanjay Kalra, Michael Benatar

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

    Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial حسب Jesús S. Mora, Angela Genge, Adriano Chió, Conrado J. Estol, Delia Chaverri, Mariluz Hernández, Saúl Marín, Javier Mascías, Gabriel Rodríguez, Mònica Povedano, Andrés Paipa, Raúl Domínguez, Josep Gámez, María Salvadó, Christian Lunetta, Carlos Ballario, Nilo Riva, Jessica Mandrioli, Alain Moussy, Jean‐Pierre Kinet, Christian Auclair, Patrice Dubreuil, Vincent Arnold, Colin D. Mansfield, Olivier Hermine

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials

    Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials حسب Leonard H. van den Berg, Eric J. Sorenson, Gary Gronseth, Eric A. Macklin, Jinsy Andrews, Robert H. Baloh, Michael Benatar, James Berry, Adriano Chió, Philippe Corcia, Angela Genge, Amelie K. Gubitz, Catherine Lomen‐Hoerth, Christopher McDermott, Erik P. Pioro, Jeffrey Rosenfeld, Vincenzo Silani, Martin R. Turner, Markus Weber, Benjamin Rix Brooks, Robert G. Miller, Hiroshi Mitsumoto

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study

    Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study حسب Stacy A. Rudnicki, Jinsy Andrews, Tina Duong, Bettina M. Cockroft, Fady I. Malik, Lisa Meng, Jenny Wei, Andrew A. Wolff, Angela Genge, Nicholas E. Johnson, Carolina Tesi Rocha, Anne M. Connolly, Basil T. Darras, Kevin J. Felice, Richard S. Finkel, Perry B. Shieh, Jean K. Mah, Jeffrey Statland, Craig Campbell, Ali A. Habib, Nancy L. Kuntz, Maryam Oskoui, John Day

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    A Phase 1 study of <scp>GDC</scp>‐0134, a dual leucine zipper kinase inhibitor, in <scp>ALS</scp>

    A Phase 1 study of <scp>GDC</scp>‐0134, a dual leucine zipper kinase inhibitor, in <scp>ALS</scp> حسب Jonathan Katz, Jeffrey D. Rothstein, Merit Cudkowicz, Angela Genge, Björn Oskarsson, Avis B. Hains, Chen Chen, Joshua Galanter, Braydon L. Burgess, Yong‐Yeon Cho, Geoffrey A. Kerchner, Felix L. Yeh, Arundhati Sengupta Ghosh, Sravanthi Cheeti, Logan Brooks, Lee Honigberg, Jessica A. Couch, Michael E. Rothenberg, Flávia Brunstein, Khema R. Sharma, Leonard van den Berg, James Berry, Jonathan D. Glass

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials

    The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials حسب Angela Genge, Jesse M. Cedarbaum, Jeremy M. Shefner, Adriano Chiò, Ammar Al‐Chalabi, Philip Van Damme, Christopher McDermott, Jonathan D. Glass, James Berry, Ruben P.A. van Eijk, Christina N. Fournier, Julian Großkreutz, Jinsy Andrews, Vanessa Bertone, Tommy M. Bunte, Mathias Couillard, Cathy Cummings, Gale Kittle, John Polzer, Kristiana Salmon, Corey Straub, Leonard H. van den Berg

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS

    Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS حسب Jonathan Mill, Merit Cudkowicz, Angela Genge, Pamela J. Shaw, Gen Sobue, Robert C. Bucelli, Adriano Chió, Philip Van Damme, Albert C. Ludolph, Jonathan D. Glass, Jinsy Andrews, Suma Babu, Michael Benatar, Christopher McDermott, Thos Cochrane, Sowmya Chary, Sheena Chew, Han Zhu, Fan Wu, Ivan Nestorov, Danielle Graham, Peng Sun, Manjit McNeill, Laura Fanning, Toby A. Ferguson, Stephanie Fradette

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: